Semiparametric regression analysis of clustered survival data with semi-competing risks

Analysis of semi-competing risks data is becoming increasingly important in medical research in which a subject may experience both nonterminal and terminal events, and the time to the intermediate nonterminal event (e.g. onset of a disease) is subject to dependent censoring by the terminal event (e...

全面介紹

Saved in:
書目詳細資料
Main Authors: Peng, Mengjiao, Xiang, Liming, Wang, Shanshan
其他作者: School of Physical and Mathematical Sciences
格式: Article
語言:English
出版: 2019
主題:
在線閱讀:https://hdl.handle.net/10356/90231
http://hdl.handle.net/10220/48475
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:Analysis of semi-competing risks data is becoming increasingly important in medical research in which a subject may experience both nonterminal and terminal events, and the time to the intermediate nonterminal event (e.g. onset of a disease) is subject to dependent censoring by the terminal event (e.g. death) but not vice versa. Typically, both two types of events are dependent. In many applications, subjects may also be nested within clusters, such as patients in a multi-center study, leading to possible association among event times due to unobserved shared factors across subjects. To incorporate dependency within clusters and association between two types of event times, we propose a new flexible semiparametric modeling framework where a copula model is employed for the joint distribution of the nonterminal and terminal events, and their marginal distributions are modeled by Cox proportional hazards models with random effects. A nonparametric maximum likelihood estimation procedure is developed and implemented through a Monte Carlo EM algorithm. The proposed estimator is also shown to enjoy desirable asymptotic properties. Results from extensive simulation studies indicate that the proposed method performs very well in finite samples and is especially robust against misspecification of the random effects distribution. We further illustrate the practical utility of the method by analyzing data from a multi-institutional study of breast cancer.